Delivery Order SPE2DX16D4016-SPE2DX26FFDDF

The U.S. Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $3,530.52 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on October 2, 2025, with an ultimate completion date of the same day. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract leverages AmerisourceBergen's comprehensive pharmaceutical and medical supply capabilities to support military healthcare operations.

AmerisourceBergen Drug Corp functions as a critical vendor within the federal medical procurement ecosystem, supplying a diverse portfolio of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order reflects AmerisourceBergen's established capability to fulfill federal medical procurement requirements through open competition, consistent with its historical performance across numerous DLA contracts ranging from minimal-value transactions to substantial orders exceeding $45,000. The firm fixed-price structure provides cost certainty for the federal government's pharmaceutical procurement needs supporting military and veteran healthcare systems.